The significance of placenta growth factor in angiogenesis and clinical outcome of human gastric cancer

被引:117
作者
Chen, CN
Hsieh, FJ
Cheng, YM
Cheng, WF
Su, YN
Chang, KJ
Lee, PH
机构
[1] Natl Taiwan Univ Hosp, Dept Surg, Coll Med, Taipei, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Gynecol & Obstet, Taipei, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Pathol, Taipei, Taiwan
[4] Natl Taiwan Univ, Angiogenesis Res Ctr, Taipei, Taiwan
关键词
vascular endothelial growth factor; microvessel density; survival; clinicopathological factor;
D O I
10.1016/j.canlet.2004.05.020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Placenta growth factor (PlGF) is a member of the vascular endothelial growth factor (VEGF) family of proangiogenic factors and its overexpression has been linked to pathological angiogenesis. We studied the relationship between the expression of PlGF and VEGF in human gastric cancer tissues and microvessel density (MVD), as well as clinical outcome in 79 patients with gastric cancer by using an enzyme immunoassay for PlGF and VEGF expression levels in gastric cancers and surrounding non-cancerous mucosa. PIGF protein levels were significantly higher in tumor than in the corresponding non-tumorous mucosa (median value 48.5 vs 9.8 pg/mg, P < 0.001). In contrast, VEGF protein levels were not (66.7 vs 80.7 pg/mg, P = 0.522). VEGF expression level was not significantly correlated with MVD, patient survival, and clinicopathological factors except Lauren classification in this study. PIGF may be an important angiogenic factor in human gastric cancer, and PIGF expression level was significantly correlated with serosal invasion, positive lymph node metastases, tumor stages, and patient survival. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:73 / 82
页数:10
相关论文
共 52 条
[1]   Role of PIGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 [J].
Autiero, M ;
Waltenberger, J ;
Communi, D ;
Kranz, A ;
Moons, L ;
Lambrechts, D ;
Kroll, J ;
Plaisance, S ;
De Mol, M ;
Bono, F ;
Kliche, S ;
Fellbrich, G ;
Ballmer-Hofer, K ;
Maglione, D ;
Mayr-Beyrle, U ;
Dewerchin, M ;
Dombrowski, S ;
Stanimirovic, D ;
Van Hummelen, P ;
Dehio, C ;
Hicklin, DJ ;
Persico, G ;
Herbert, JM ;
Communi, D ;
Shibuya, M ;
Collen, D ;
Conway, EM ;
Carmeliet, P .
NATURE MEDICINE, 2003, 9 (07) :936-943
[2]   EXPRESSION OF THE VASCULAR-PERMEABILITY FACTOR VASCULAR ENDOTHELIAL GROWTH-FACTOR GENE IN CENTRAL-NERVOUS-SYSTEM NEOPLASMS [J].
BERKMAN, RA ;
MERRILL, MJ ;
REINHOLD, WC ;
MONACCI, WT ;
SAXENA, A ;
CLARK, WC ;
ROBERTSON, JT ;
ALI, IU ;
OLDFIELD, EH .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (01) :153-159
[3]   VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) GENE IS EXPRESSED DIFFERENTIALLY IN NORMAL-TISSUES, MACROPHAGES, AND TUMORS [J].
BERSE, B ;
BROWN, LF ;
VANDEWATER, L ;
DVORAK, HF ;
SENGER, DR .
MOLECULAR BIOLOGY OF THE CELL, 1992, 3 (02) :211-220
[4]   NOVEL GROWTH REGULATORY FACTORS AND TUMOR ANGIOGENESIS [J].
BICKNELL, R ;
HARRIS, AL .
EUROPEAN JOURNAL OF CANCER, 1991, 27 (06) :781-785
[5]  
BREIER G, 1992, DEVELOPMENT, V114, P521
[6]  
BROWN LF, 1993, CANCER RES, V53, P4727
[7]   Placenta growth factor: Identification and characterization of a novel isoform generated by RNA alternative splicing [J].
Cao, YH ;
Ji, WDR ;
Qi, P ;
Rosin, A ;
Cao, YM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 235 (03) :493-498
[8]   Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions [J].
Carmeliet, P ;
Moons, L ;
Luttun, A ;
Vincenti, V ;
Compernolle, V ;
De Mol, M ;
Wu, Y ;
Bon, F ;
Devy, L ;
Beck, H ;
Scholz, D ;
Acker, T ;
DiPalma, T ;
Dewerchin, M ;
Noel, A ;
Stalmans, I ;
Barra, A ;
Blacher, S ;
Vandendriessche, T ;
Ponten, A ;
Eriksson, U ;
Plate, KH ;
Foidart, JM ;
Schaper, W ;
Charnock-Jones, DS ;
Hicklin, DJ ;
Herbert, JM ;
Collen, D ;
Persico, MG .
NATURE MEDICINE, 2001, 7 (05) :575-583
[9]  
CHAMOCKJONES DS, 1993, BIOL REPROD, V48, P1120
[10]  
Donnini S, 1999, J PATHOL, V189, P66, DOI 10.1002/(SICI)1096-9896(199909)189:1<66::AID-PATH390>3.0.CO